emitted in the environment. Their presence in the atmosphere occurs both naturally (i.e., bacterial processes, biological growth and decay) and due to man's activities (i.e., fossil fuels).
NO is one of the biomarkers of oxidative stress, which has in turn been investigated as a possible mechanism explaining ASD pathogenesis [5] . Oxidative stress may act as a result of the cumulative influence of toxic environmental factors, which could lead to neuronal damage in genetically predisposed individuals [5] . NO is involved in many neuropsychiatric disorders and is known to affect neurodevelopmental processes in the central nervous system [6] . Indeed, elevated NO plasma levels have been found in subjects with ASD compared with control groups [7] . In addition, a positive correlation between ASD and perinatal exposure to air pollution, in particular NO and NO 2 , has been found [8] .
Since both high plasma ammonia and high plasma NO have been observed in subjects with ASD [6, 7] , elevated levels of N 2 O might also be hypothesized. It has been suggested that high amounts of N 2 O could explain the observation of uncontrollable laughter and high pain tolerances seen in some subjects with ASD [9] . However, to the best of our knowledge, until now there has been no study evaluating the N 2 O level in subjects with ASD and correlating it with ASD symptoms.
It could be hypothesized, as Dr Fluegge suggested, that N 2 O could mediate vitamin D reduction in ASD. It has been suggested, for example, that N 2 O could reduce solar radiation, therefore having an adverse effect by reducing vitamin D synthesis by the mother and thereby vitamin D insufficiency in the neonate, leading to susceptibility to respiratory infection and other conditions [10] . Our review on the association between ASD and vitamin D [11] has suggested a putative role of vitamin D in the etiology of ASD, at least in a subgroup of subjects.
However, it is worth mentioning that none of the studies that we have analyzed in our systematic reviews on AD [2] and vitamin D [11] have evaluated N 2 O in the association among AD, vitamin D, and ASD. Therefore, further studies need to be performed to elucidate the possible role of N 2 O in the interaction between vitamin D and AD, and in the etiology of ASD.
Moreover, the toxicity of N 2 O has been assessed in healthy individuals and is still controversial [12] , although it seems that it could cause adverse effects in certain vulnerable populations. Finally, further studies are needed to elucidate the possible use of opioid antagonists for ASD treatment since they could improve hyperactivity and restlessness without having an impact on core features of ASD in the majority of the participants [13] .
In conclusion, in our opinion it is important to bear in mind that ASD is an heterogeneous disorder and that its etiology is multifactorial, so N 2 O exposure might be one of the putative factors contributing to the pathogenesis of ASD, particularly in a subset of genetically susceptible individuals. Furthermore, the use of opioid antagonists and similar medications for ASD treatment should be considered with caution in a subgroup of individuals with specific characteristics.
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